Management of Elevated TSH in Patients on Levothyroxine

Assessment and Diagnosis

A TSH of 4.62 while on levothyroxine therapy indicates suboptimal thyroid hormone replacement, as the goal is to maintain TSH within the reference range, according to the American Medical Association 2
This represents subclinical hypothyroidism in a treated patient, which requires dose adjustment to normalize TSH, as recommended by the American Medical Association 1
When subclinical hypothyroidism is noted in levothyroxine-treated patients with overt hypothyroidism, the dosage should be adjusted to bring the serum TSH into the reference range, as suggested by the American Medical Association 1

Increase the levothyroxine dose from 75 mcg to achieve a TSH within the normal reference range, as recommended by the American Medical Association 1, 2
The rapidity of dosage adjustment depends on the patient's age and medical comorbidities, according to the American Medical Association 1

Repeat thyroid function tests in 6-8 weeks after dose adjustment to assess response, as suggested by the American Medical Association, although this specific guideline is from Praxis Medical Insights, a similar recommendation is likely from other societies 3
Continue to adjust the dose until TSH normalizes, as recommended by the American Medical Association 2

Normalizing TSH is important as it may prevent symptoms and signs of overt hypothyroidism, according to the American Medical Association 2

If the patient is pregnant or planning pregnancy, more aggressive TSH normalization is warranted, as recommended by the American Medical Association 1, 3
Pregnant women often require increased levothyroxine doses, and TSH should be monitored every 6-8 weeks during pregnancy, according to the American Medical Association 1, 3
The target TSH during pregnancy is typically in the lower half of the reference range, as suggested by the American Medical Association 1